Thrombopoietin: in vitro predictions, in vivo realities.
Division of Hematology, University of Washington, Seattle, USA.
K
K
Kaushansky
D000818:Animals; D001792:Blood Platelets / Q000166:cytology*; D002454:Cell Differentiation / Q000187:drug effects; D019070:Cell Lineage; D006410:Hematopoiesis / Q000187:drug effects*; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D007378:Interleukins / Q000494:pharmacology / Q000502:physiology; D007942:Leukemia, Experimental / Q000378:metabolism / Q000503:physiopathology; D008322:Mammals / Q000502:physiology; D008533:Megakaryocytes / Q000166:cytology; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D008954:Models, Biological; D019089:Stem Cell Factor / Q000494:pharmacology / Q000502:physiology; D013926:Thrombopoietin / Q000494:pharmacology / Q000502:physiology*
D007378:Interleukins; D019089:Stem Cell Factor; D013926:Thrombopoietin